keyboard_arrow_up

In-Depth Review on Global Cardiopulmonary Autotransfusion Systems Market 2016-2020

Report : Global Cardiopulmonary Autotransfusion Systems Market 2016-2020 is a new market research publication announced by Reportstack.

Report Outline: Autotransfusion involves the collection of blood before surgeries and its transfusion during cardiac operations. This procedure is processed in autotransfusion systems that help minimize blood loss by collecting and filtering the RBCs, and reinfusing the blood into an individual.

Autotransfusion is an autologous technology involving the retransfusion of a person's own blood, which increases the need for traditional centrifuge devices for separating the RBCs from the blood. Advances in technology have led companies to integrate ultrafiltration technique for blood collection. For instance, Advancis Surgical's ultrafiltration-based HemoSep system can improve patient recovery time by filtering inflammatory molecules, preserving normal clotting function, and maintaining platelet populations.

For detailed report with TOC, please click here ​Global Cardiopulmonary Autotransfusion Systems Market 2016-2020.

Market Growth: The global cardiopulmonary autotransfusion systems is expected to grow at a CAGR of 1.91% during the period 2016-2020.

Key vendors: 
• Advancis Surgical
• Fresenius Kabi
• Haemonetics
• LivaNova
• Medtronic
• Terumo

Other prominent vendors: 
• Atrium Medical
• Global Blood Resources
• Redax
• Sarstedt
• Stryker 

Regions Covered:

• Americas
• APAC
• EMEA

Companies Mentioned

Advancis Surgical, Fresenius Kabi, Haemonetics, LivaNova, Medtronic, Terumo, Atrium Medical, Global Blood Resources, Redax, Sarstedt, and Stryker.

Contact:

Debora White

Manager - Marketing

debora@reportstack.com

Ph: +1-888-789-6604

Reportstack Market Research

###